Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 97,565 | 94,851 | 9,792 | 2,124 | 5,584 |
| Other current assets | 1,019 | 64 | 252 | 346 | 0 |
| TOTAL | $104,227 | $96,686 | $11,684 | $3,209 | $5,689 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 7 | 7 |
| Other Non-Current Assets | 0 | 0 | 1 | 189 | 296 |
| TOTAL | $N/A | $N/A | $1 | $196 | $303 |
| Total Assets | $104,227 | $96,686 | $11,685 | $3,405 | $5,992 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,041 | 3,157 | 2,073 | 448 | 860 |
| Accrued Expenses | 1,115 | 1,536 | 1,013 | 775 | 704 |
| TOTAL | $7,156 | $4,693 | $3,587 | $1,848 | $1,564 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 64 | 184 |
| TOTAL | $N/A | $N/A | $N/A | $64 | $184 |
| Total Liabilities | $7,156 | $4,693 | $3,587 | $1,912 | $1,748 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,198 | 3,970 | 1,958 | 280 | 16 |
| Common Shares | 1 | N/A | N/A | 0 | 3 |
| Retained earnings | -367,454 | -314,855 | -297,253 | -289,542 | -278,494 |
| TOTAL | $97,071 | $91,993 | $8,098 | $1,493 | $4,245 |
| Total Liabilities And Equity | $104,227 | $96,686 | $11,685 | $3,405 | $5,992 |